Anergis Patents – Insights & Stats (Updated 2023)

Anergis has a total of 69 patents globally, out of which 44 have been granted. Of these 69 patents, more than 30% patents are active. The United States of America is where Anergis has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also Switzerland is the origin country of Anergis.

Anergis was founded in 2001. Anergis produces pharmaceutical drugs. In order to promote desensitization to common allergens, the company develops and evaluates biopharmaceutical allergy vaccines.

Do read about some of the most popular patents of Anergis which have been covered by us in this article and also you can find Anergis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Anergis patent portfolio.

How many patents does Anergis have?

Anergis has a total of 69 patents globally. These patents belong to 8 unique patent families. Out of 69 patents, 21 patents are active.

How Many Patents did Anergis File Every Year?

Anergis Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAnergis Applications FiledAnergis Patents Granted
20211
20205
20192
20183
201716
201625
201514
2014124
201323
2012101
201122

How many Anergis patents are Alive/Dead?

Worldwide Patents

Anergis Patent Portfolio

How Many Patents did Anergis File in Different Countries?

Anergis Worldwide Patent Filing

Countries in which Anergis Filed Patents

CountryPatent
United States Of America12
Europe9
Japan9
Australia7
Canada6
Denmark3
Germany3
Spain3
Austria2
Poland2
Hungary1
Turkey1
Slovenia1
Brazil1
China1
Croatia1
Russia1
Hong Kong (S.A.R.)1

Where are Research Centers of Anergis Patents Located?

The Research Centers of Anergis Patents is the United States of America.

10 Best Anergis Patents

US8075897B2 is the most popular patent in the Anergis portfolio. It has received 18 citations so far from companies like Regeneron Pharmaceuticals, Sanofi Biotechnology, Divine Api-Logics.

Below is the list of 10 most cited patents of Anergis:

Publication NumberCitation Count
US8075897B218
US20150050301A114
US7923209B28
CN105307679A8
US6780416B16
US6878376B25
US9005627B22
JP05390742B22
US8343503B21
US9808503B21

What Percentage of Anergis US Patent Applications Were Granted?

Anergis (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 75 have been granted leading to a grant rate of 75%.

Below are the key stats of Anergis patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Anergis?

Law FirmTotal ApplicationsSuccess Rate
Marshall Gerstein & Borun966.67%
Ivor R Elrifi1100.00%
Jeffrey S Sharp1100.00%
Mintz Levin Boston Office1100.00%

What are Anergis key innovation segments?

What Technologies are Covered by Anergis?

The chart below distributes patents filed by Anergis in different countries on the basis of the technology protected in patents. It also represents the markets where Anergis thinks it’s important to protect particular technology inventions.

R&D Focus: How has Anergis search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Anergis?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.